Will the Long-Named Perfluorohexyloctane Produce Long-lasting Improvements in Patients With Meibomian Gland Disease?
JAMA Ophthalmol
.
2023 Apr 1;141(4):392-393.
doi: 10.1001/jamaophthalmol.2023.0399.
Authors
Gerami D Seitzman
1
2
,
Thomas M Lietman
1
2
Affiliations
1
Francis I. Proctor Foundation, San Francisco, California.
2
Department of Ophthalmology, University of California, San Francisco.
PMID:
36928282
DOI:
10.1001/jamaophthalmol.2023.0399
No abstract available
Publication types
Comment
MeSH terms
Dry Eye Syndromes*
Eyelid Diseases*
Fluorocarbons*
Humans
Meibomian Glands
Tears
Substances
perfluorohexyl-octan
Fluorocarbons